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Poster Presentations: Wednesday, July 17, 2019 S1537not significantly associated with rate of amyloid accumulation over
several years. These preliminary results are in line with mechanistic
hypotheses suggesting that mTBI may not affect rate of Ab accu-
mulation. Limitations of the current study include a relatively small
sample size, a generally healthy sample with low variance in Ab
burden and number of mTBI, and limited information regarding cir-
cumstances of mTBI, potential unreported exposures to mTBI (e.g.,
in sports), and symptomatology of past mTBI.We are currently col-
lecting a more detailed mTBI history and scanning participants at 8
years post-baseline to test additional convergent hypotheses
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eduBackground: Numerous studies show that sensitivity to stress in-
creases the risk for Alzheimer’s disease (AD), with mechanisms
related to increased glucorticoid exposure presumed to underlie
this association. Meanwhile, the mechanisms by which the single
largest genetic risk factor for sporadic AD—the apolipoprotein E
(APOE) ε4 allele— is thought to increase AD risk via its role in fac-
tors associated with regulating lipid transport. We propose that this
gene may also exert its effects on AD risk by influencing glucocor-
ticoid activity. Although the presence of APOE ε4 is associated
with increased stress hormone (cortisol) levels in older adults and
in those with AD, such findings might be attributable to the effects
of incipient AD on stress hormone levels. We hypothesized that if
variants in the APOE gene pose a risk for AD due to mechanisms
related to glucocorticoid activity, then this association should be
evident much earlier in the lifespan.Methods: In 413 healthy adults
(18 – 29 years; 279 women), we measured salivary stress hormones
at 3 time points before and 5 time points after an acute stressor (the
Trier Social Stress Test). After excluding 9 individuals with the
APOE 2/4 genotype, we compared salivary cortisol levels among
three groups based on number of APOE ε4 alleles (0, 1, or 2) in a
repeated-measures analysis of covariance controlling for sex and
race. We also analyzed various parameters of the cortisol stressresponse, including area under the curve, and change in cortisol
in response to stress. Results: Individuals who were homozygous
for the APOE ε4 allele (n¼8) had higher cortisol levels at baseline
and following the acute stressor than did those with either 1 (n¼90)
or 0 (n¼306) ε4 alleles (F¼4.49; p¼.01); individuals with 1 APOE
ε4 allele did not differ from those with 0 ε4 alleles (see Figure).
Conclusions: Results from this study suggest that the increased
AD risk conferred by the APOE ε4allele may be related to its influ-
ence on stress hormones, which can be appreciated even in young
adulthood. These findings support targeting glucocorticoid activity
in AD risk prevention efforts, and beginning those efforts early.P4-570 REPEATED BASELINE EEG MEASURESARE EFFECTIVE FOR DISCRIMINATION
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Background: Age and disease related cognitive declines have
important socioeconomic implications. Differentiating between
amnestic (those with highest risk of Alzheimer’s disease) from
non-amnestic elderly with mild cognitive impairment (MCI) is vital
for elucidating the underlying mechanisms for accelerated cogni-
tive decline and potentially guiding interventions for preventing
or slowing MCI. We propose a novel approach for differentiating
between different MCI subgroups by using repeated electrophysio-
logical recording prior to and following visuospatial cognitive stim-
ulation.Methods: Forty-one consensus MCI diagnosed community
dwelling African American older participants (28 amnestic, 13
non-amnestic MCI) over age 60 years received two resting EEG
(eyes closed) recordings between which participants engaged in a
visual motion direction discrimination task (known to reflect integ-
rity of the hippocampus) for approximately 20 minutes. The
outcome measures were % changes of spectral power between
pre/post EEGs. Results: There was a decrease in spectral power
of eyes-closed EEG across the frequency ranges at post as
compared pre-EEG recording: aMCI showed the greatest decrease
of baseline EEG spectral power at the theta (4-8 Hz) across all the
ROIs – 4 - 12% (p<.005), and posterior occipital ROIs at beta range
(12-30 Hz) – 4 - 6% (p<.05), while no-aMCI showed significant %
change of spectral power at frontal theta range (4-8 Hz) (p ¼ .04).
The significant % decrease between the two groups was observed at
frontal theta ROI (aMCI ¼ 13%, No-aMCI ¼ 4%; p < .05). Multi-
ple regression showed that % decrease in frontal and right temporal
theta significantly predict groupmembership between amnestic and
non-amnesticMCI patients (R2¼ 23%, p¼ .006).Conclusions: Our
preliminary results demonstrate that EEG reactivity, defined as %
change in repeated eyes-closed baseline EEG after short visual
cognitive stimulation, showed distinct, significant decreases in am-
nestic MCI as compared to non-amnestic participants primarily in
frontal theta and beta frequency range. Baseline EEG reactivity
findings are novel and promising in terms of differentiating be-
tween different subtypes of MCI, as well as older adults who
are most at risk for accelerated cognitive decline and Alzheimer’s
disease.
